2019 Symposium

2018 Symposium

2017 Symposium

2016 Symposium

2015 Symposium

2015 Agenda and Bios

2015 Symposium Photos

Previous Symposia

2019 Featured Talks » Ewa Carrier

Clinical Perspective: Targeting CTGF in Locally Advanced Pancreatic Cancer

Ewa Carrier, MD
Executive Director of Clinical Development, Fibrogen

Ewa Carrier, MD
Executive Director of Clinical Development

Dr. Ewa Carrier is Executive Director of Clinical Development at FibroGen, Inc. Prior to FibroGen, she was VP of Medical Affairs at NovaRx Corporation, and Director of Clinical Development and Medical Affairs at Boehringer Ingelheim, developing cancer vaccines and first-in-class PLK inhibitor. Dr. Carrier is a board certified hematologist/oncologist and transplant physician, who spent most of her career in academia, where she trained at Stanford and held a faculty position at the University of California, San Diego from 1997-2012 in the Hematology and Transplant Division. She developed unique mouse model of prenatal transplantation and contributed to the development of reduced toxicity transplants for patients with hematologic malignancies. She also developed a novel patented technology for developing off shelf human red blood cells. She is member of ASH, ASCO and AACR, and is currently focused on the development of new therapies for cancer.